Editas Medicine
Massachusetts, United States
201-500 Employees
Healthcare
•Tech
Associate Corporate
Cambridge, --
Description
Editas Medicine (NASDAQ: EDIT) is a leading biotechnology company that specializes in genome editing. Founded with a vision to harness the power of CRISPR technology, Editas Medicine is at the forefront of developing innovative therapies to address genetic diseases. Their groundbreaking research and development efforts have the potential to revolutionize the field of medicine by offering targeted treatments for a wide range of genetic disorders. Editas Medicine is dedicated to advancing...
Financials
Type
public
Annual Revenue
--
Market Cap
$115.3M+
Subscribe to Refer Me premium to get referred to this role at Editas Medicine!